Human sperm deoxyribonucleic acid fragmentation by specific types of papillomavirus

Connelly, Diane A.; Chan, Philip J.; Patton, William C.; King, Alan

doi:10.1067/mob.2001.115226

Cited by 57 publications

(80 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Efficacy of Gardasil® obtained against HPV31-induced CIN2/3 is around 55%. Finally, 43% protection was obtained against CIN2/3 induced by 14 oncogenic and non oncogenic genotypes of HPV (HPV 6,11,16,18,31,33,35,39,45,51,52,56,58,59) 3.7 years after vaccination.…”

Section: Prophylactic Vaccines Can Prevent Infectionmentioning

confidence: 99%

“…An efficacy of 70% and 43% was obtained against CIN2/3 related to 14 oncogenic HPVs (16,18,31,33,35,39,45,51,52,56,58,59,66,68) with Cervarix® and 12 oncogenic HPVs (16,18,31,33,35,39,45,51,52,56,58,59) with Gardasil®, respectively (http://www.ema.europa.eu/, gardasil®, summary of product characteristics). A high level of anti-HPV antibodies usually correlates with a broad recognition of B-cell epitopes.…”

Section: Prevention Of Infection By Other Oncogenic Hpvs By Divalent mentioning

confidence: 99%

“…The phase III trial involved more than 20 000 subjects and was approved by the FDA and European Medical Agency. 70% protection was obtained against CIN2/3 related to 14 oncogenic HPV genotypes (HPV 16,18,31,33,35,39,45,51,52,56,58,59, 66, 68) 3 years following vaccination (Paavonen et al, 2009). The efficacy of Cervarix® against HPV31-induced CIN2/3 is around 92%.…”

Section: Prophylactic Vaccines Can Prevent Infectionmentioning

confidence: 99%

“…Among 18 large peptides of the proteins E6 and E7, two were recognized in proliferative assays as immunodominant by T cells from 10 out of 16 women (62%) at the entry in the study, namely E6/2 (aa 14-34) and E6/4 (aa peptides. Four other peptides, E6/7 (aa 91-110), E7/2 (aa 7-27), E7/3 (aa [21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40] and E7/7 (aa 65-87) were recognized by only 12% of the women in proliferative or IFNγ ELISPOT tests. The regions of E6 and E7 proteins implicated in T cell recognition during HPV infection…”

Section: How To Determine the Epitopic Regions For A Therapeutic Vaccmentioning

confidence: 99%

See 3 more Smart Citations

Human Papillomavirus and Related Diseases - From Bench to Bedside - A Clinical Perspective

Broeck¹

2012

View full text Add to dashboard Cite

Section: Prophylactic Vaccines Can Prevent Infectionmentioning

confidence: 99%

Section: Prevention Of Infection By Other Oncogenic Hpvs By Divalent mentioning

confidence: 99%

Section: Prophylactic Vaccines Can Prevent Infectionmentioning

confidence: 99%

Section: How To Determine the Epitopic Regions For A Therapeutic Vaccmentioning

confidence: 99%

See 2 more Smart Citations

Human Papillomavirus and Related Diseases - From Bench to Bedside - A Clinical Perspective

Broeck¹

2012

View full text Add to dashboard Cite

“…They have been categorized as either low-risk types (lrHPV) or highrisk types (hrHPV) depending on their oncogenic potential [2]. Following HPV types are considered as high risk: 16,18,31,33,35,39,45,51,52,56,58,59 68, 73, and 82. Types 26,53, and 66 are considered as probable high risk (phr).…”

Section: Human Papillomavirus (Hpv) Is the Most Common Sexually Transmentioning

confidence: 99%

Human Papillomavirus in Donor Semen in Belgium

D’Hauwers¹,

Tjalma²,

Punjabi³

et al. 2012

Human Papillomavirus and Related Diseases - From Bench to Bedside - A Clinical Perspective

View full text Add to dashboard Cite

Current Awareness

2001

Prenatal Diagnosis

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of prenatal diagnosis. Each bibliography is divided into 17 sections: 1 Books, Reviews & Symposia; 2 General Interest; 3 Normal Fetal Development; 4 Gametogenesis and Pre‐implantation Diagnosis; 5 First Trimester Diagnosis; 6 Second Trimester Diagnosis; 7 Fetal Diagnosis by Ultrasound and Other Imaging; 8 Maternal Screening; 9 Screening for Carriers of Genetic Abnormality; 10 Technological Developments; 11 Confined Placental Mosaicism and Uniparental Disomy; 12 Molecular Cytogenetics; 13 Fetal Cells in Maternal Circulation; 14 Fetal Therapy; 15 Psychosocial Aspects; 16 Epidemiology and Environmental Factors; 17 Developmental Pathology. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted

show abstract

Human sperm deoxyribonucleic acid fragmentation by specific types of papillomavirus

Cited by 57 publications

References 8 publications

Human Papillomavirus and Related Diseases - From Bench to Bedside - A Clinical Perspective

Human Papillomavirus and Related Diseases - From Bench to Bedside - A Clinical Perspective

Human Papillomavirus in Donor Semen in Belgium

Current Awareness

Contact Info

Product

Resources

About